I.W. Kellaway

4.5k total citations · 1 hit paper
140 papers, 3.7k citations indexed

About

I.W. Kellaway is a scholar working on Molecular Biology, Pharmaceutical Science and Organic Chemistry. According to data from OpenAlex, I.W. Kellaway has authored 140 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 45 papers in Pharmaceutical Science and 30 papers in Organic Chemistry. Recurrent topics in I.W. Kellaway's work include Lipid Membrane Structure and Behavior (32 papers), Advanced Drug Delivery Systems (28 papers) and Surfactants and Colloidal Systems (23 papers). I.W. Kellaway is often cited by papers focused on Lipid Membrane Structure and Behavior (32 papers), Advanced Drug Delivery Systems (28 papers) and Surfactants and Colloidal Systems (23 papers). I.W. Kellaway collaborates with scholars based in United Kingdom, Spain and United States. I.W. Kellaway's co-authors include Jonathan Hadgraft, J. D. Smart, H E C Worthington, Glyn Taylor, Stephen J. Farr, Helena Cabral-Marques, Jaehwi Lee, Kevin Taylor, Sudaxshina Murdan and Nigel Davies and has published in prestigious journals such as Advanced Drug Delivery Reviews, Langmuir and Gut.

In The Last Decade

I.W. Kellaway

137 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery

1984 395 citations I.W. Kellaway et al. Journal of Pharmacy and Pharmacology profile →

Peers

Countries citing papers authored by I.W. Kellaway

Since Specialization

Citations

This map shows the geographic impact of I.W. Kellaway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.W. Kellaway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.W. Kellaway more than expected).

Fields of papers citing papers by I.W. Kellaway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I.W. Kellaway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.W. Kellaway. The network helps show where I.W. Kellaway may publish in the future.

Co-authorship network of co-authors of I.W. Kellaway

This figure shows the co-authorship network connecting the top 25 collaborators of I.W. Kellaway. A scholar is included among the top collaborators of I.W. Kellaway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I.W. Kellaway. I.W. Kellaway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insulin nanoparticles: Stability and aerosolization from pressurized metered dose inhalers 2009 ·International Journal of Pharmaceutics ·(unknown), I.W. Kellaway, Kevin Taylor	34
2	Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles 2006 ·International Journal of Pharmaceutics ·(unknown), I.W. Kellaway, Sudaxshina Murdan	180
3	Novel sustained release microspheres for pulmonary drug delivery 2005 ·Journal of Controlled Release ·(unknown), (unknown), I.W. Kellaway	129
4	Surfactant solubility and aggregate orientation in hydrofluoroalkanes 2005 ·International Journal of Pharmaceutics ·(unknown), (unknown), I.W. Kellaway	22
5	The inhibition of phagocytosis of respirable microspheres by alveolar and peritoneal macrophages 2002 ·International Journal of Pharmaceutics ·(unknown), Paul A. Dickinson, Mark Gumbleton, I.W. Kellaway	39
6	Nebulisation of rehydrated freeze-dried beclomethasone dipropionate liposomes 2001 ·International Journal of Pharmaceutics ·Yusrida Darwis, I.W. Kellaway	52
7	Physical stability and in-vitro gene expression efficiency of nebulised lipid–peptide–DNA complexes 2000 ·International Journal of Pharmaceutics ·James C. Birchall, I.W. Kellaway, Mark Gumbleton	56
8	Microcalorimetry does not predict the cellular phagocytosis of latex microspheres 2000 ·International Journal of Pharmaceutics ·(unknown), Mark Gumbleton, I.W. Kellaway, Paul Dickinson	1
9	Buccal permeation of [d-Ala2, d-Leu5]enkephalin from liquid crystalline phases of glyceryl monooleate 2000 ·International Journal of Pharmaceutics ·Jaehwi Lee, I.W. Kellaway	46
10	Improved Nasal Bioavailability of FITC-Dextran (M_w4300) from Mucoadhesive Microspheres in Rabbits 1999 ·Journal of drug targeting ·(unknown), I.W. Kellaway, Glyn Taylor, Paul A. Dickinson	23
11	The transport of polymeric microspheres across the ciliated epithelia of the bullfrog 1999 ·International Journal of Pharmaceutics ·(unknown), Herman Baker, I.W. Kellaway	4
12	Absorption Enhancers as Tools to Determine the Route of Nasal Absorption of Peptides 1998 ·Journal of drug targeting ·Andrew J. Donnelly, I.W. Kellaway, Glyn Taylor, Mark Gibson	14
13	Evaluation of Mucoadhesive Polymers in Ocular Drug Delivery. II. Polymer-Coated Vesicles 1992 ·Pharmaceutical Research ·Nigel Davies, Stephen J. Farr, Jonathan Hadgraft, I.W. Kellaway	63
14	Studies of cyclodextrin inclusion complexes. III. The pulmonary absorption of β-, DM-β- and HP-β-cyclodextrins in rabbits 1991 ·International Journal of Pharmaceutics ·Helena Cabral-Marques, Jonathan Hadgraft, I.W. Kellaway, Glyn Taylor	40
15	High Sperformance liquid chromatographic analysis of liposome stability 1990 ·Journal of Microencapsulation ·William G. Love, N. Amos, Bryan Williams, I.W. Kellaway	16
16	Differential scanning calorimetry of dimethylsulphoxide-treated human stratum corneum 1989 ·International Journal of Pharmaceutics ·(unknown), I.W. Kellaway	16
17	Effect of liposome surface charge on the stability of technetium (^99mTc) radiolabelled liposomes 1989 ·Journal of Microencapsulation ·William G. Love, N. Amos, Bryan Williams, I.W. Kellaway	21
18	The Thermodynamics of Partitioning of Phenothiazines between Phosphate Buffer and the Lipid Phases of Cyclohexane, n-Octanol and DMPC Liposomes 1985 ·Pharmaceutical Research ·(unknown), (unknown), I.W. Kellaway	25
19	Direct effect of bile salts and phospholipids on the physical properties of mucus. 1978 ·Gut ·Gary P. Martin, C Marriott, I.W. Kellaway	113
20	Mechanical properties of gelatin films 1974 ·Journal of Pharmacy and Pharmacology ·John A. Robinson, I.W. Kellaway, C Marriott	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact